Ana Ortega

2.0k total citations
76 papers, 1.4k citations indexed

About

Ana Ortega is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Ana Ortega has authored 76 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 14 papers in Pediatrics, Perinatology and Child Health and 13 papers in Geriatrics and Gerontology. Recurrent topics in Ana Ortega's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Pharmaceutical studies and practices (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Ana Ortega is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Pharmaceutical studies and practices (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Ana Ortega collaborates with scholars based in Spain, United States and Canada. Ana Ortega's co-authors include J. Giráldez, Amalio Telenti, S.T. Cole, C. Bernasconi, Nadine Honoré, Béate Heym, Howard Takiff, Azucena Aldaz, Bernardo Santos‐Ramos and Alfredo García‐Layana and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Ana Ortega

74 papers receiving 1.3k citations

Peers

Ana Ortega
Kamal Sud Australia
Daniel Dedman United Kingdom
Kimberly G. Brodovicz United States
Robert M. Perkins United States
Essy Mozaffari United States
Helen Kastrissios United States
Anantharaman Vathsala Singapore
Valentina Perrone Italy
Stefan Herget‐Rosenthal Germany
Yuan Xu Canada
Kamal Sud Australia
Ana Ortega
Citations per year, relative to Ana Ortega Ana Ortega (= 1×) peers Kamal Sud

Countries citing papers authored by Ana Ortega

Since Specialization
Citations

This map shows the geographic impact of Ana Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Ortega more than expected).

Fields of papers citing papers by Ana Ortega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Ortega. The network helps show where Ana Ortega may publish in the future.

Co-authorship network of co-authors of Ana Ortega

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Ortega. A scholar is included among the top collaborators of Ana Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Ortega. Ana Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trapero‐Bertran, Marta, et al.. (2025). Reform of economic evaluation of medicines in Spain: proposals from the Advisory Committee for Pharmaceutical Financing. Gaceta Sanitaria. 39. 102439–102439. 2 indexed citations
2.
Trapero‐Bertran, Marta, Juan Oliva, Ferrán Catalá-López, et al.. (2025). Guideline for the economic evaluation of medicines: a proposal by the Spanish National Health System's Advisory Committee for Pharmaceutical Financing. Gaceta Sanitaria. 39. 102448–102448. 1 indexed citations
3.
Leache, Leire, et al.. (2018). Evidence of clinical and economic impact of pharmacist interventions related to antimicrobials in the hospital setting. European Journal of Clinical Microbiology & Infectious Diseases. 37(5). 799–822. 8 indexed citations
4.
5.
Ortega, Ana, et al.. (2012). Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH. Farmacia Hospitalaria. 36(4). 176–179. 4 indexed citations
6.
Ortega, Ana, et al.. (2011). Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH. Farmacia Hospitalaria. 35(3). 140–147. 5 indexed citations
7.
8.
Pueyo, Francisco Javier, L. López-Olaondo, M.J. Sánchez-Ledesma, Ana Ortega, & F. Carrascosa. (2003). Cost-effectiveness of three combinations of antiemetics in the prevention of postoperative nausea and vomiting. British Journal of Anaesthesia. 91(4). 589–592. 24 indexed citations
9.
Ortega, Ana, et al.. (2003). Effect of nitroglycerine in popliteal preparations from patients with peripheral occlusive arteriopathy precontracted with KCl or 5‐hydroxytryptamine. Clinical and Experimental Pharmacology and Physiology. 30(8). 528–531. 1 indexed citations
10.
Moreno, Raúl, José López‐Sendón, Eulogio Garcı́a, et al.. (2002). Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. Journal of the American College of Cardiology. 39(4). 598–603. 93 indexed citations
11.
Ortega, Ana, et al.. (2001). Integración y aplicaciones de los estudios de farmacoeconomía e investigación de resultados en salud en los diferentes niveles asistenciales. 1 indexed citations
12.
Aleixandre, Amaya, Visitación López‐Miranda, & Ana Ortega. (2001). α-Vascular Responses After Short-Term and Long-Term Inhibition of Nitric Oxide Synthesis. Journal of Cardiovascular Pharmacology. 37(2). 133–142. 10 indexed citations
13.
Ortega, Ana, et al.. (2000). Cost analysis of neuromuscular blocking agents in the operating room: cisatracurium, atracurium, vecuronium and rocuronium.. Pharmacy World & Science. 22(3). 82–87. 3 indexed citations
14.
Martı́n-Sanz, Paloma, Lisardo Boscá, Luis Olmedilla, et al.. (1999). Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation. Clinical Transplantation. 13(3). 221–230. 7 indexed citations
15.
Ortega, Ana, Azucena Aldaz, J. Giráldez, & Antonio Brugarolas. (1999). Relationship between pharmacokinetic parameters of gentamicin and patient characteristics and/or clinical data in patients with solid organ tumours.. Pharmacy World & Science. 21(5). 227–232. 3 indexed citations
16.
Ortega, Ana, et al.. (1998). A Clinical and Economic Evaluation of Red Blood Cell Transfusions in Patients Receiving Cancer Chemotherapy. International Journal of Technology Assessment in Health Care. 14(4). 788–798. 14 indexed citations
17.
Ortega, Ana, et al.. (1998). What are cancer patients willing to pay for prophylactic epoetin alfa?. Cancer. 83(12). 2588–2596. 49 indexed citations
18.
Moreno, Raúl, et al.. (1998). Determinants of a positive exercise test in patients admitted with acute non-infarct chest pain. International Journal of Cardiology. 66(2). 147–151. 5 indexed citations
19.
Cháves, Fernando, Fernando Dronda, M. Donald Cave, et al.. (1997). A Longitudinal Study of Transmission of Tuberculosis in a Large Prison Population. American Journal of Respiratory and Critical Care Medicine. 155(2). 719–725. 88 indexed citations
20.
Ortega, Ana, Miguel Puerro, Visitación López‐Miranda, & Amaya Aleixandre. (1997). The role of endothelium in the calcium-induced reduction of the contractile response of the rabbit aorta. General Pharmacology The Vascular System. 28(5). 745–752. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kamal Sud Breakdown of academic impact, for papers by Daniel Dedman Breakdown of academic impact, for papers by Kimberly G. Brodovicz Breakdown of academic impact, for papers by Robert M. Perkins Breakdown of academic impact, for papers by Essy Mozaffari Breakdown of academic impact, for papers by Helen Kastrissios Breakdown of academic impact, for papers by Anantharaman Vathsala Breakdown of academic impact, for papers by Valentina Perrone Breakdown of academic impact, for papers by Stefan Herget‐Rosenthal Breakdown of academic impact, for papers by Yuan Xu
Rankless by CCL
2026